DuPont de Nemours vs Eastman Chemical
DD and EMN side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How DD and EMN compare
DuPont de Nemours is the larger company, worth 2.8 times as much as Eastman Chemical ($21.2B against $7.6B).
On earnings, Eastman Chemical is cheaper: it trades at 12.2× trailing earnings, against 349× for DuPont de Nemours.
DuPont de Nemours grew revenue faster over the last twelve months (3.3% versus 0.27% for Eastman Chemical).
Eastman Chemical keeps more of each dollar of sales as profit, with a net margin of 6.9% compared with 0.79% at DuPont de Nemours.
Both pay dividends: DuPont de Nemours yields 1.5% and Eastman Chemical 5.1%.
Eastman Chemical scores higher on the StockData Score (16 against 8 for DuPont de Nemours), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | DD | EMN |
|---|---|---|
| Size and price | ||
| Market cap | $21.2B | $7.6B |
| Share price | $156.88 | $66.51 |
| Change, 1 year | 31.4% | 8.1% |
| Change, 5 years | −34.6% | −41.2% |
| Beta (5Y) | 1.14 | 1.10 |
| Employees | 15K | 13K |
| StockData Score | ||
| Total score | 8 | 16 (better) |
| Valuation score | 0 | 5 (better) |
| Growth score | 2 (better) | 1 |
| Performance score | 0 | 2 (better) |
| Health score | 4 (better) | 2 |
| Dividend score | 2 | 6 (better) |
| Valuation | ||
| P/E | 349× | 12.2× (better) |
| P/S | 3.0× | 0.8× (better) |
| P/B | 1.5× | 1.2× (better) |
| EV/EBITDA | 24.8× | – |
| P/FCF | 30.2× | 16.2× (better) |
| FCF yield | 3.3% | 6.2% (better) |
| Fair value | $98.38 | $93.06 |
| Margin of safety | −59.5% | 28.5% (better) |
| Growth | ||
| Revenue growth (TTM) | 3.3% (better) | 0.27% |
| Revenue growth, 5Y average | −9.3% | 0.65% (better) |
| Net income growth (TTM) | – | −13.3% |
| EPS growth (TTM) | – | −12.3% |
| EPS growth, 5Y average | – | 3.2% |
| Profitability | ||
| Gross margin | 35.1% (better) | 20.6% |
| Net margin | 0.79% | 6.9% (better) |
| FCF margin | 10.0% (better) | 5.2% |
| Return on equity | 0.30% | 10.4% (better) |
| Financial health | ||
| Debt / equity | 0.23 (better) | 0.83 |
| Net debt / EBITDA | 1.52 | – |
| Current ratio | 2.43 (better) | 1.57 |
| Altman Z-score | 0.65 | 2.15 (better) |
| Piotroski F-score | 6 (better) | 5 |
| Dividends and buybacks | ||
| Dividend yield | 1.5% | 5.1% (better) |
| Payout ratio | 758% | 61.1% |
| Years of dividend growth | 0 | 16 (better) |
| Dividend growth, 5Y average | 3.6% | 4.5% (better) |
| Buyback yield | −0.64% | – |
| Shareholder yield | 0.89% | 5.1% (better) |
| Ownership | ||
| Held by institutions | 73.7% | 94.1% |
| Held by insiders | 0.75% | 0.83% |
| Insider net buying, 12 months | −$14.2M | −$206K (better) |
| Superinvestors holding | – | 1 |
| Short interest, % of float | 2.9% | 4.9% |
Go deeper
- DD stock overview
- DD income statement
- DD valuation and score
- EMN stock overview
- EMN income statement
- EMN valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.